FDA approves ProHeart 12July 8, 2019The U.S. Food and Drug Administration’s (FDA’s) Center for Veterinary Medicine (CVM) has approved ProHeart 12 (moxidectin) extended release injectable suspension for dogs one year and older.
SPONSORED CONTENTUncompromising renal + sensitivities care.Help manage sensitivities + chronic kidney disease with the power of Prescription Diet k/d + z/d Hydrolyzed. + Learn More